ARRDC3 regulates the targeted therapy sensitivity of clear cell renal cell carcinoma by promoting AXL degradation

.

Source: Cell Cycle - February 23, 2024 Category: Cytology Authors: Mulin ChenBingde YinYao LiuMingzi LiSuqin ShenJiaxue WuWeiguo LiJie Fana Department of Urology, Shanghai General Hospital,Shanghai Jiaotong University, School of Medicine, Shanghai, P.R. Chinab Department of Urology, Minhang Hospital, Fudan University, Sh Source Type: research